Glucose & Insulin

About the New Omnipod Insulin Delivery System

The Omnipod Closed-Loop Insulin Delivery System is a hybrid closed-loop (HCL) system: it combines the technology of continuous glucose monitoring (CGM) and insulin pumps, and a personalized control algorithm to deliver insulin as needed, day and night. Research showed it helped patients stay in their target glucose range. Read more

Is Insulin in Pill Form Finally Here?

Researchers have been working on a way to deliver insulin in pill form instead of via injection for a long time, an innovation that would make the lives of people with type 1 diabetes much easier. However, they have struggled to find a method that would allow insulin to survive the human digestive system. Now […]

Options for More Affordable Insulin

Newer types of insulin can be very hard to afford for people who have no insurance coverage, or poor prescription coverage. Regular and NPH insulin are much more affordable, but you need to learn about the best ways to make use of them. For some guidance, read more

When Weight Loss Isn’t a Good Sign

Weight loss is usually a beneficial thing for people with diabetes. However, it’s important not to lose sight of the fact that weight loss is sometimes a sign of a problem — and one problem that can cause unexpected weight loss is high glucose levels. A diabetes educator shares why it’s so important to look […]

A Patch to Replace the Fingerstick

Scientists have created an adhesive skin patch that measures blood glucose levels every 10-15 minutes — a potential replacement for the fingerstick blood tests which many patients find painful. Created by researchers from the University of Bath in the United Kingdom, the patch has performed well in tests of its function as a noninvasive strategy […]

Why Checking A1c Before Any Surgery is Essential

Surgery places physical stress on the patient, and patients with diabetes and hyperglycemia are especially vulnerable to complications from surgery. A recent study found that poor glycemic control before surgery (elevated HbA1c levels) was a major risk factor for adverse outcomes after surgery. The research demonstrates the need to assess patients’ glycemic levels prior to […]

An Analysis of the American College of Physicians Controversial New Recommendations

The American College of Physicians recently issues new guidelines stating that adults with type 2 diabetes can aim for an easier-to-achieve blood sugar target than what’s been used to guide treatment in the past. These recommendations differ from the guidelines from most national and international organizations, such as the American Diabetes Association and American Association […]

ADA and Doctor’s Group Disagree on Blood Sugar Goals

A new recommendation from the American College of Physicians that many people with type 2 should relax their blood sugar goals has drawn strong disagreement from the American Diabetes Association (ADA). Based on research analysis, the College has decided that the problems caused by trying for for the lowest blood sugar score outweigh the benefits, […]

Study Raises Insulin Quality Concerns – But is it Accurate?

A pharmacist recent conducted a study of the quality of insulin. He tested 18 vials, purchased at pharmacies, and found that on average the vials had less than half what was listed on the vial. But were his methods accurate, and does such a small study really mean anything? Insulin makers, advocacy groups and diabetes […]

Do Voice-Operated Apps for Insulin Pumps Really Work?

The VoiceDiab is an Android app that works through voice recognition. Users can speak to the app, giving descriptions of their meals.  The app then calculates needed insulin doses to compensate for the content of the meals. 887 basic foods are programmed into the app with information about their caloric value and amounts of carbs, […]

Will New Once-Daily Pill Replace Insulin Injections?

Novo Nordisk, the world’s largest insulin manufacturer, is looking to transform the diabetes market with a pill. Its oral semaglutide medicine is currently in late-stage trials, with a planned launch date in 2020. Semaglutide, one of the GLP-1 drugs, stimulates insulin production. It’s currently available as a once-weekly injection, and Novo hopes that the pill […]

How Tech Can Help Patients Get Over Motivation Slumps

People who have been dealing with type 1 since childhood can get “burned out” on dealing with their diabetes every day, and lose the motivation to test numbers regularly and do the other tasks they need to do to manage their diabetes. For some of those patients, new technologies like CGMs can make managing their […]

Freestyle Libre Now Covered by Medicare

Abbott’s FreeStyle Libre, a continuous glucose monitoring system (CGM) has received Medicare coverage. This CGM is the first in the market that does not require diabetes patients to prick their finger to draw blood. The Medicare coverage and ease of use of the system are expected to make it an attractive option for senior citizens […]

Oral Insulin Not Adequate To Prevent Type 1

Taking a 7.5 mg dose of oral insulin every day doesn’t seem to be effective in delaying the onset of type 1 diabetes. A recent study followed a group of people who all tested positive for microinsulin antibodies and had a relative who’d been diagnosed with type 1 diabetes. Half the study participants took the […]

What are Biosimilars, and What Do They Mean for Diabetes Treatment?

A biosimilar is a biological product defined as being comparable (but not identical) to an already FDA-approved biological product, in molecular structure, safety, and effectiveness. Because they are not identical to the reference product, they differ from generic drugs, which have identical molecular structures and active ingredients to those of the brand name products. The […]

New Treatment for Insulin Resistance May Be On the Way

Insulin resistance, which occurs when the body’s cells are no longer able to respond to insulin, is a major risk factor for developing type 2 diabetes. For people with insulin resistance, blood glucose levels can become too high, which over time can contribute to the development of type 2. Currently, medications such as thiazolidinediones are […]

FDA Approves New Rapid-Acting Mealtime Insulin

It’s been shown that maintaining low glucose levels after meals can slow the progression of diabetes-associated complications. Researchers have been looking at ways to create an ultrafast insulin that is quickly absorbed into the bloodstream and can rapidly affect glucose levels. This way, the patient can take insulin after meals and quickly get post-meal glucose […]

New Artificial Pancreas Trial Shows Benefits for Type 1

Participants with type 1 diabetes in a 12-week clinical trial showed significant improvements in two important health measures. Their HbA1c decreased and the amount of time they spent in hypoglycemia was reduced. The artificial pancreas system consists of an insulin pump and continuous glucose monitor, surgically placed under a patient’s skin, and is designed to […]

Animas to Stop Making Insulin Pumps

Johnson & Johnson has decided to discontinue its insulin pump products. The Animas, Animas Vibe, and OneTouch Ping pumps will no longer be available. The company announced it has  partnered with Medtronic to transition its existing customers to Medtronic’s pump line. Johnson & Johnson representatives have said the decision to shut down the pump division […]

Insulin Patch Offers Alternative to Shots

The V-Go insulin patch offers people with diabetes an alternative to insulin injections. After you load the patch with insulin, it is applied to the arm, leg or abdomen, much like a Band-Aid. There’s a tiny needle inside the patch. With a push of a button, the needle goes into the skin. It delivers a […]